Skip to main content

Vista AI

Category: AI in Healthcare

An AI-powered software platform that automates MRI image acquisition, transforming complex scans into a simplified, high-quality 'one-click' procedure. Vista AI was founded in 2008. The company is led by Daniel Hawkins. Based in Palo Alto, USA. Team size: 11-50. Total funding raised: $38.2M total. Latest round: Series B ($29.5M, Jan 2026). Key investors include ["Insight Partners","Khosla Ventures","NVentures (NVIDIA)","7wireVentures","Mizuho Bank"].

Founded
2008
Headquarters
Palo Alto, USA
Team size
11-50
Total funding
$38.2M total

Value proposition

Reduces MRI scan times by up to 30% and eliminates the need for highly specialized technicians by automating complex positioning and sequence selection, ensuring consistent diagnostic quality.

Products and solutions

["One-Click MRI™ (Core automation platform)","AI-driven Cardiac Suite (Specialized cardiac imaging automation)","Automated Slice Positioning (Real-time anatomical alignment)","Vista.ai Cloud (Data analytics and performance monitoring)"]

Unique value

Unlike most medical AI that focuses on post-scan image analysis, Vista AI operates during the 'acquisition' phase, controlling the MRI hardware in real-time to guide the scan itself.

Target customer

Health systems, diagnostic imaging centers, and hospitals facing MRI technologist shortages or seeking to increase patient throughput.

Industries served

["Healthcare","Medical Imaging","HealthTech","Artificial Intelligence"]

Technology advantage

Vendor-neutral software compatible with major MRI manufacturers (GE, Siemens, Philips), allowing hospitals to standardize complex procedures across diverse hardware fleets without retraining staff.

How they differentiate

Unlike post-processing AI that enhances images after acquisition, Vista AI provides real-time, vendor-neutral hardware control that automates the entire scanning process (positioning and sequences), reducing the need for highly specialized MRI technicians.

Main competitors

["Subtle Medical","GE HealthCare (AIR Recon DL)","Siemens Healthineers (Deep Resolve)"]

Key partnerships

["NVIDIA (NVentures investment and technical collaboration)","Sutter Health (Clinical validation and development partner)","Insight Partners (Strategic growth and scaling)","Major MRI OEMs (Integration and compatibility partnerships)"]

Notable customers

["Sutter Health","West Virginia University (WVU) Medicine"]

Major milestones

["Received FDA 510(k) clearance for Cardiac MRI software","Rebranded from HeartVista to Vista AI to reflect expansion beyond cardiac imaging","Appointed MedTech veteran Daniel Hawkins as CEO in March 2024","Closed $29.5M Series B funding round in 2024"]

Growth metrics

Achieved up to 30% reduction in MRI scan times and enabled 3x higher patient throughput in clinical settings.

Market positioning

Specialized AI-driven workflow automation provider for diagnostic imaging centers and hospital systems.

Geographic focus

North America

Patents and IP

The leadership team holds over 160 patents; the company maintains a robust IP portfolio specifically covering automated MRI pulse sequences and real-time AI-guided image acquisition.

About Daniel Hawkins

Daniel Hawkins is a veteran MedTech executive and serial entrepreneur with over 30 years of experience in the healthcare sector. Prior to joining Vista AI as CEO in March 2024, he was the Founder and CEO of Avail Medsystems. He is most notably the co-founder of Shockwave Medical (Nasdaq: SWAV), where he served as the initial CEO and invented the core technology. His background includes pivotal early leadership roles at Intuitive Surgical, where he drove the market creation for the DaVinci surgical robot, and managerial positions at Guidant (Abbott Vascular). He holds over 160 patents.

Official website: